– USA, CA – Ceres, Inc. (CERE), an agricultural biotechnology and seed company, announced today that Aflalo Guimaraes has joined its board of directors. Mr. Guimaraes succeeds Raymond Debbane, who retired from Ceres’ board.
“Mr. Debbane, who was nominated to the Ceres board by Artal Luxembourg, our largest stockholder, has been a steadfast proponent of our technology and intellectual property portfolio, and we have appreciated his support and service to our board as we moved ahead with the advancement and commercialization of our seed products, traits and genomic technologies. We look forward to working with Mr. Guimaraes, who brings extensive financial and business expertise to our board,” said Ceres President and CEO Richard Hamilton.
Aflalo Guimaraes is a managing director of The Invus Group, LLC, an affiliate of Artal Luxembourg S.A. Prior to joining Invus in 1998, he was a manager at Marakon Associates where he led strategic consulting engagements for large multi-national companies in a wide range of industries, including financial services, retail and consumer products. He previously worked at the U.S. Federal Reserve. Mr. Guimaraes holds an MBA from the University of Pennsylvania’s Wharton School and a BA in Economics and Political Science from Yale University. He currently serves on the boards and audit committees of a number of private companies.
About Ceres
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for bioenergy and other markets that utilize plant biomass. The company combines advanced plant breeding and biotechnology to develop hybrids that can address the limitations of first-generation bioenergy feedstocks. These technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other organizations.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
